Mohammad taher Hojjati

Dr. Mohammad taher Hojjati

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012
Verified
Closed access
MKMehrnoush Kosaryan
Mehrnoush Kosaryan
MMMohammad Reza Mahdavi
Mohammad Reza Mahdavi
PRPayam Roshan
Payam Roshan
MHMohammad taher Hojjati
Mohammad taher Hojjati

4 March 2017 in Hemoglobin
Verified
Journal Article
Closed access
MHMohammad taher Hojjati
Mohammad taher Hojjati
AAAzita Azarkeivan
Azita Azarkeivan
APAli A. Pourfathollah
Ali A. Pourfathollah
NANaser Amirizadeh
Naser Amirizadeh
Drug induction of Hb F seems to be an ideal therapy for patients with hemoglobin (Hb) disorders, and many efforts have been made to reveal the mechanism behind it. Thus, we examined in vivo expression of some microRNAs (miRNAs) that are thought to be involved in this process. Among β-thalassemia (β-thal) patients who were undergoing hydroxyurea (HU) therapy in the past 3 months and five healthy individuals, five responders and five non-responders, were also included in the study. Erythroid progenitors were isolated by magnetic activated cell sorting (MACS) and miRNA expression analyzed using reverse transcription-polymerase chain reaction (RT-PCR). We showed that γ-globin, miR-210 and miR-486-3p had higher levels in the responders than the non-responders group. Moreover, miR-150 and miR-320 had higher levels in the healthy group than both non-responders and responders groups, but the expression of miR-96 did not show any significant difference between the study groups. To the best of our knowledge, this is the first study proposing that 'induction of cellular hypoxic condition by Hb F inducing agents' could be the milestone of possible mechanisms that explain why responders are able to reactivate γ-globin genes and subsequently, more production of Hb F, in response to these agents in comparison to non-responders. However, further investigations need to be performed to verify this hypothesis.

1 July 2011
Verified
Journal Article
Closed access
MHMohammad taher Hojjati
Mohammad taher Hojjati
NENahid Einollahi
Nahid Einollahi
FNFariba Nabatchian
Fariba Nabatchian
APAli Akbar Pourfathollah
Ali Akbar Pourfathollah
MMMohammad Reza Mahdavi
Mohammad Reza Mahdavi

29 May 2019 in Transfusion Clinique et Biologique
Verified
Journal Article
Closed access
RRRomina Rahmani
Romina Rahmani
PNParisa Naseri
Parisa Naseri
ASAva Safaroghli-Azar
Ava Safaroghli-Azar
STShahriar Tarighi
Shahriar Tarighi
THTahereh Hosseini
Tahereh Hosseini
MHMohammad taher Hojjati
Mohammad taher Hojjati

1 February 2015
Verified
Journal Article
Closed access
BGBehruz Ghezelbash
Behruz Ghezelbash
SKSedigheh Amini Kafiabad
Sedigheh Amini Kafiabad
MHMohammad taher Hojjati
Mohammad taher Hojjati
MHMohsen Hamidpoor
Mohsen Hamidpoor
SVShahram Vaeli
Shahram Vaeli
AGAhmad Gharehbaghian
Ahmad Gharehbaghian

1 October 2013 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
MMMohammad Reza Mahdavi
Mohammad Reza Mahdavi
AAAbolghasem Amami
Abolghasem Amami
TTTarang Taghvaie
Tarang Taghvaie
PRPayam Roshan
Payam Roshan
MHMohammad taher Hojjati
Mohammad taher Hojjati
VHVahid Hoseini
Vahid Hoseini